A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics - Crone, Michael A.; Priestman, Miles; Ciechonska, Marta; Jensen, Kirsten; Sharp, David J.; Anand, Arthi; Randell, Paul; Storch, Marko; Freemont, Paul S. (Nature communications, 2020)
Keywords: 38/56; 38/77; 38/88; 38/90; 631/1647/2163; 631/61/32; 631/61/338/552; 692/699/255; Automation; Betacoronavirus - genetics; Betacoronavirus - isolation & purification; Biological Assay; Clinical Laboratory Techniques - instrumentation; Clinical Laboratory Techniques - methods; Clinical Laboratory Techniques - standards; Coronavirus Infections - diagnosis; Coronavirus Infections - virology; COVID-19; COVID-19 Testing; CRISPR; CRISPR-Cas Systems; Diagnostic systems; Gene amplification; Humanities and Social Sciences; Humans; Molecular Diagnostic Techniques - methods; multidisciplinary; Nucleic Acid Amplification Techniques - methods; Pandemics; Pneumonia, Viral - diagnosis; Pneumonia, Viral - virology; Reagents; Real-Time Polymerase Chain Reaction; Ribonucleic acid; RNA; RNA, Viral - analysis; RNA, Viral - genetics; RNA, Viral - isolation & purification; SARS-CoV-2; Science; Science (multidisciplinary); Sensitivity and Specificity; Severe acute respiratory syndrome coronavirus 2; Viral diseases; Virus-like particles; Viruses; Workflow